2,N,N-TMT

From Wikipedia, the free encyclopedia

2,N,N-TMT
Systematic (IUPAC) name
(2-(2-methyl-1H-indol-3-yl)-1-methyl-ethyl)dimethylamine
Identifiers
CAS number  ?
ATC code  ?
PubChem  ?
Chemical data
Formula C13H18N2 
Mol. mass 202.30 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

2,N,N-trimethyltryptamine (2,N,N-TMT, 2-Me-DMT, 2-TMT) is a tryptamine derivative that is a hallucinogenic drug. It was invented by Alexander Shulgin and reported in his book TiHKAL (#34) [1]. It is claimed to show psychoactive effects at a dosage of 50-100mg orally, but these are relatively mild compared to other similar drugs, suggesting that while the 2-methyl group has blocked the binding of metabolic enzymes, it is also interfering with binding to the 5HT2A receptor target that mediates the hallucinogenic effects of these drugs.

[edit] References

  1. ^ Erowid Online Books : "TIHKAL" - #34 2-ME-DMT